Carregant...
Sulfasalazine for treating rheumatoid arthritis
BACKGROUND: Sulfasalazine has become a common second line drug (DMARD) for the treatment of rheumatoid arthritis (RA). OBJECTIVES: To estimate the short‐term efficacy and toxicity of sulfasalazine for the treatment of rheumatoid arthritis (RA). SEARCH METHODS: We searched the Cochrane Musculoskeleta...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
1998
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7047550/ https://ncbi.nlm.nih.gov/pubmed/10796400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000958 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|